Related content

Gene therapeutics in Sjögren’s syndrome

By Bolstad Anne Isine   Jonsson Roland  

Expert Opinion on Biological Therapy, Vol. 5, Iss. 6, 2005-06 ,pp. : 763-772

Informa Healthcare

Access to resources Recommend Favorite

Analyses of functional IL10 and TNF-α genotypes in Behçet’s syndrome

By Ateş Omer   Dalyan Levent   Hatemi Gulen   Hamuryudan Vedat   Topal-Sarıkaya Aysegul  

Molecular Biology Reports, Vol. 37, Iss. 7, 2010-10 ,pp. : 3637-3641

Springer Publishing Company

Access to resources Recommend Favorite

A failure of TNFAIP3 negative regulation maintains sustained NF-κB activation in Sjögren’s syndrome

By Sisto Margherita   Lisi Sabrina   Lofrumento Dario   Ingravallo Giuseppe   Maiorano Eugenio   D’Amore Massimo  

Histochemistry and Cell Biology, Vol. 135, Iss. 6, 2011-06 ,pp. : 615-625

Springer Publishing Company

Access to resources Recommend Favorite

Targeting TNF-α for the treatment of inflammatory bowel disease

By Billiet Thomas   Rutgeerts Paul   Ferrante Marc   Van Assche Gert   Vermeire Séverine  

Expert Opinion on Biological Therapy, Vol. 14, Iss. 1, 2014-01 ,pp. : 75-101

Informa Healthcare

Access to resources Recommend Favorite

Recombinant adenoviral expression of IL-10 protects beta cell from impairment induced by pro-inflammatory cytokine

By Xu Ai-Jing   Zhu Wei   Tian Fei   Yan Li-Hua   Li Tang  

Molecular and Cellular Biochemistry, Vol. 344, Iss. 1-2, 2010-11 ,pp. : 163-171

Springer Publishing Company

Access to resources Recommend Favorite